We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVEE
9301
DELISTED
NV5 Global
NVEE
$244K ﹤0.01%
12,364
-51,688
-81% -$870K
SPYV icon
9302
PUT
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.6B
$244K ﹤0.01%
+7,100
New +$231K
TDSC icon
9303
Exchange Listed Funds Trust ETC Cabana Target Drawdown 10 ETF
TDSC
$103M
$244K ﹤0.01%
+9,899
New +$243K
CNCE
9304
CALL
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$244K ﹤0.01%
19,300
-2,900
-13% -$33.1K
RALS
9305
DELISTED
ProShares RAFI Long/Short
RALS
$244K ﹤0.01%
8,008
-190
-2% -$5.76K
AMTX icon
9306
CALL
Aemetis
AMTX
$115M
$243K ﹤0.01%
+97,700
New +$297K
CPS icon
9307
CALL
Cooper-Standard Automotive
CPS
$491M
$243K ﹤0.01%
+7,000
New +$195K
FLN icon
9308
First Trust Latin America AlphaDEX Fund
FLN
$36.5M
$243K ﹤0.01%
12,546
-304
-2% -$5.19K
O icon
9309
Realty Income
O
$58.2B
$243K ﹤0.01%
4,033
-639,770
-99% -$37.8M
REKR icon
9310
PUT
Rekor Systems
REKR
$89M
$243K ﹤0.01%
+30,100
New +$164K
ABB
9311
PUT
DELISTED
ABB Ltd
ABB
$243K ﹤0.01%
8,700
-99,100
-92% -$2.64M
EPZM
9312
CALL
DELISTED
Epizyme, Inc
EPZM
$243K ﹤0.01%
+22,400
New +$276K
QTS
9313
DELISTED
QTS REALTY TRUST, INC.
QTS
$243K ﹤0.01%
3,919
-154,786
-98% -$9.68M
BANR icon
9314
CALL
Banner Corp
BANR
$2.4B
$242K ﹤0.01%
+5,200
New +$214K
BRX icon
9315
Brixmor Property Group
BRX
$9.25B
$242K ﹤0.01%
+14,601
New +$207K
EUDG icon
9316
WisdomTree Europe Quality Dividend Growth Fund
EUDG
$70.3M
$242K ﹤0.01%
+7,975
New +$230K
FCG icon
9317
First Trust Natural Gas ETF
FCG
$621M
$242K ﹤0.01%
27,387
-62,088
-69% -$473K
ARTNA icon
9318
Artesian Resources
ARTNA
$355M
$241K ﹤0.01%
+6,505
New +$242K
ASPS icon
9319
PUT
Altisource Portfolio Solutions
ASPS
$66M
$241K ﹤0.01%
2,338
-1,475
-39% -$152K
CLBK icon
9320
CALL
Columbia Financial
CLBK
$1.13B
$241K ﹤0.01%
+15,500
New +$214K
CLIX icon
9321
ProShares Long Online/Short Stores ETF
CLIX
$7.48M
$241K ﹤0.01%
2,605
-657
-20% -$58.2K
EWI icon
9322
PUT
iShares MSCI Italy ETF
EWI
$1.07B
$241K ﹤0.01%
8,200
-2,900
-26% -$78.1K
PLUR icon
9323
PUT
Pluri
PLUR
$19.5M
$241K ﹤0.01%
4,263
-2,812
-40% -$205K
RYAM icon
9324
CALL
Rayonier Advanced Materials
RYAM
$618M
$241K ﹤0.01%
36,900
+16,100
+77% +$85.3K
ESCR
9325
DELISTED
Xtrackers Bloomberg US Investment Grade Corporate ESG ETF
ESCR
$241K ﹤0.01%
10,553
+126
+1% +$2.86K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.